Purpose: To determine whether a risk calculator changes treatment recommendations made by glaucoma specialists in cases of ocular hypertension.
T he concept of formal risk estimation has recently been introduced to the management of ocular hypertension. There are now at least 3 calculators that estimate the risk of developing glaucoma in those with elevated intraocular pressure (IOP). [1] [2] [3] The concept of clinical risk estimation using epidemiologic data has previously been applied to the risk of myocardial infarction, using results from the Framingham Study. 4 In the case of ocular hypertension, the current calculators are based entirely or in part on the results of the Ocular Hypertension Treatment Study (OHTS). 5 Although risk calculators have been used in medicine for many years, their impact on physician decision-making and on improving patient outcomes is not yet clear. A recent study of a Framingham-derived calculation found minimal, if any, change in the management of cardiovascular disease by physicians when a risk assessment was introduced into a clinical setting. 6 As risk calculation is relatively new to ophthalmology, its impact has not yet been evaluated.
There are at least 2 central questions related to the impact of risk calculators in cases of ocular hypertension. First, do treatment recommendations made by ophthalmologists already reflect the underlying risk of developing glaucoma (ie, do clinicians need a calculator?). Second, does the addition of a risk calculator change the decisionmaking behavior of physicians? If the answer to the first question is yes and the answer to the second question is no, then risk calculators may not be needed, or their role in patient care needs to be reconsidered.
In support of the need for risk calculators, Mansberger and Cioffi 7 have reported that ophthalmologists do not agree in their assessment of glaucoma risk for individual ocular hypertensive patients. This inability to estimate risk is not surprising, given the complexity of integrating 6 risk factors when making a clinical decision. 8, 9 We sought to evaluate a different approach, namely to determine whether physician treatment recommendations are reflective of the underlying risk of glaucoma rather than their ability to assign a numeric value to each patient. We feel this approach is more consistent with clinical practice. A similar approach, applied to treatment of breast cancer, suggested that physician decisions are to some degree correlated with underlying risk of disease. 10 To address these questions, we designed a study in which physicians reviewed case scenarios of ocular hypertension and were asked how likely they would be to recommend treatment. The recommendations were made for 2 groups of patients-one that included a risk calculation and one that did not. In this way, we were able to determine whether the recommendations reflected risk (using the group without a calculation) and whether the calculator changed recommendations (comparing the recommendations for the 2 groups). We composed the 2 groups of patients (with and without calculator presented) so that 1 member of each group had the same risk of developing glaucoma. Finally, we compared physician recommendations without and with the calculator data and measured both the impact of individual risk factors in physician decision-making and how the weighting of those risk factors was influenced by the calculator. By making comparisons between physician behavior and the results of a large randomized study, the findings of this work also relate directly to the effect of clinical trial data on clinical practice.
METHODS
The design of this study was reviewed and approved by the Johns Hopkins University School of Medicine Institutional Review Board.
Data Collection
To maintain consistency with the OHTS, 50 cases of ocular hypertension were generated using the summary statistics of the OHTS population. 5 Using the published proportions, means, and standard deviations, we generated values for sex and the OHTS-identified risk factors for initial glaucoma: age, IOP, cup-disc ratio (CDR), pattern standard deviation (PSD) from automated field testing, central corneal thickness (CCT), and self-reported diabetes mellitus. Values for the continuous parameters were drawn from normal distributions. Wherever appropriate, values of risk factors in our scenarios were restricted on the basis of OHTS inclusion and exclusion criteria.
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A second group of patients was generated so that each scenario in the group had the same risk as one of the scenarios in the first group. To accomplish this, the riskfactor values generated from the first group were modified in a systematic fashion such that the estimated 5-year risk of glaucoma was maintained. The effect of each parameter on the risk estimate was determined by taking partial derivatives of the risk equation described by Medeiros et al. 2 On the basis of the marginal contribution of individual risk factors to the overall risk estimate, each of the 50 patients' scenarios was modified by first randomly increasing or decreasing the CDR by 0.1. If the CDR was increased, then age was decreased by 5 years, IOP was reduced by 1 mm Hg, PSD was decreased by 0.1 dB, and CCT was decreased by 4 mm. If CDR was decreased, then the changes in the other risk factors were made in the opposite direction. Because of its large effect on risk, diabetic status was maintained between all pairs. The value for the 5-year estimated risk of glaucoma was then added to the data for each scenario in the second group using the equation described by Medeiros et al. 2 The 2 groups of cases were statistically identical ( Table 1) . The log-normal distribution for estimated risk of developing glaucoma in a population with characteristics derived from the OHTS is shown in Figure 1 . This distribution from simulated cases has the same summary statistics reported by Medeiros et al 2 for the Diagnostic Innovations in Glaucoma Study (DIGS) population.
The order of the cases in 2 groups of patients, one without a risk estimate and one with, was randomized and they were inserted into a web-based tool. Participants were instructed to review scenarios including values for all 6 OHTS risk factors plus patient sex one by one. For each simulated patient, the physicians were asked how likely they would be to recommend treatment to prevent glaucoma. Participants were explicitly instructed that this recommendation represented their initial position in their discussion with the patient. To recruit participants, we sent an e-mail message to members of the American Glaucoma Society (AGS). To prevent bias in recruitment of physicians, recipients were not told the subject of the study. Because of the estimated time required to complete the study (30 to 45 min) and to further reduce any selection bias, they were also offered compensation for their time. Once they accessed the website, physicians were provided with a brief consent document. If they agreed to participate, they were first asked questions intended to identify and exclude physicians who either always or never treat ocular hypertension. Physicians who did not report using IOP as the sole criteria for treatment were then asked to review 50 case scenarios without a calculated risk value and 50 cases with the risk value given. Participants were all asked to provide their sex, racial background, number of years in practice, subspecialty training, monthly clinic volume, fraction of practice devoted to glaucoma, and whether they use a risk calculator in their practice.
Statistical Analysis
The 7-point treatment recommendation scale was collapsed into 3 levels. Definitely No and Probably No were combined as ''No,'' Possibly No, and Unsure, and Possibly Yes were combined as Unsure, whereas Probably Yes and Definitely Yes were labeled ''Yes.'' This approach is widely used in the analysis of Likert-scale data to make subsequent regression analysis more understandable. In this case, the final 3-point scale was used to maintain the concept of uncertainty in the recommendations.
To determine whether physician treatment recommendations reflected the underlying risk of glaucoma, we carried out ordinal regression on the responses from each physician using the treatment recommendation as the dependent variable and the risk estimate as the independent variable. The results were summarized as the proportion of physicians for whom risk was statistically significant (Pr0.05) in the regression model. The regression coefficients for risk were also plotted along with their standard error.
To further assess the relationship between risk and treatment recommendations, we performed ordinal regression on the combined set of recommendations made by physicians on the cases presented without a risk estimate. In this model, we included physician sex, selfreported race, length of practice, monthly patient volume, proportion of glaucoma patients in the practice, and current use of a risk calculator to control for the possible effects of these variables on treatment recommendations. An independent variable was considered a statistically significant predictor of treatment recommendations if it carried a P value r0.05 using a Wald Z test. To compare the magnitude of the model coefficients with one another, we normalized each variable by dividing it by its standard error. The algorithm used for all regression analyses also reported a pseudo-R 2 value using the method of Nagelkerke. 12 The overall impact of the risk calculation on treatment recommendations was assessed in 2 ways. First, the distribution of Yes, Unsure, and No recommendations was calculated for the 2 groups of cases using all physician responses. Second, a k statistic was calculated for each physician using the risk-matched pairs of patients (one without a risk calculation, one with).
To describe how recommendations changed, we examined the data in 4 ways. First, the recommendations for each risk-matched pair were recorded and summarized in a bar plot, evaluating the effect of the calculation on recommendations. Second, we estimated what we characterize as the confidence of the physician in his/her recommendation and how it was altered by the presence of the calculator. This was done by calculating the proportion of a physician's recommendations that were either Yes or No (ie, excluding those that were Unsure). Third, we created a measure called inconsistency, which would be highest for a physician who was equally likely to assign a patient with a given risk to any of the 3 treatment categories (Yes, Unsure, No). Similarly, inconsistency would be lowest (best) for a physician who made recommendations strictly on the basis of risk while also using firm boundaries between recommendation levels. We operationalized this measure for each physician as the sum of the variances of risk in each of their 3 treatment recommendation groups (No, Unsure, Yes). Finally, we calculated the empiric risk threshold for recommending treatment for each physician. This threshold was derived from ordinal regression models generated for each physician and was calculated for both groups of patients (with and without a risk estimate). Briefly, using the formulas underlying ordinal regression, we derived an expression for the risk at which a recommendation was equally likely to be Yes or No (ie, the physician was the most unsure). The risk thresholds obtained for each physician's recommendations without a risk calculation were compared with those made with a risk calculation using the paired t test.
To determine how physicians used the results of the OHTS when making treatment recommendations, ordinal regression models were generated for each physician using the trichotomous recommendation from the scenarios without a risk calculation as the dependent variable and OHTS risk factors (age, IOP, CDR, PSD, CCT, and diabetes) as independent variables. A particular risk factor was considered statistically significant in a given physician's model if it produced a P value r0.05 using the Wald Z test. As a related analysis, ordinal regression Estimated risk of glaucoma Proportion FIGURE 1. Distribution of risk in an ocular hypertensive population. This distribution was created by generating risk factors for 20,000 cases of ocular hypertension using the characteristics reported by the OHTS. The risk for each case was calculated using the formula described by Medeiros et al. 2 was performed on the combined set of responses from all physicians in each of the 2 groups of scenarios, with and without a risk estimate. Once again, the treatment recommendation was the dependent variable, whereas patient sex, age, IOP, CDR, PSD, CCT, and diabetes status were independent variables. To allow for some comparison to be made with the Cox model generated by the OHTS investigators, we scaled the regression coefficients from our models to match the units of the OHTS hazard ratios. 5 For example, the coefficient for age was multiplied by 10 to match the OHTS convention of presenting the hazard ratio per decade. Similarly, the coefficients for CDR, PSD, and CCT were multiplied by 0.1, 0.2, and 40, respectively. The coefficients for the OHTS Cox model were estimated by taking the natural logarithm of the reported hazard ratios. All statistical analysis was carried out using R version 2.4.0 (www. r-project.org) along with the Design package. 13 
RESULTS
As expected, subjects from the AGS were nearly all glaucoma subspecialty-trained and an average of three fourths of their patients have glaucoma (Table 2) . Almost 50% of the physicians reported presently using a risk calculator at least some of the time. Of the 58 respondents, 2 reported recommending treatment to every patient with an eye pressure over 21 mm Hg. As these participants were not using multiple risk factors in determining their treatment recommendation, their responses were not included in further analysis.
The relationship between physician treatment recommendations and the underlying risk of glaucoma was assessed using ordinal regression and each physician's recommendations made without a risk estimate. By this measure, glaucoma risk was a statistically significant predictor of the treatment recommendation for 91% of physicians. The regression coefficients for risk, along with their standard errors, from all physicians are plotted in Figure 2 . This relationship was further analyzed by combining all 2800 responses from physicians on the cases presented without a risk calculation. Again, the model indicated that physicians were more likely to treat those at higher risk (Pr0.001; Table 3 ). Risk remained significant even when controlling for other variables and The coefficients for physician race are compared with a baseline of ''White,'' those for calculator use are compared with a baseline of ''Never,'' and the coefficient for physician gender is for males compared with females. Coefficients less than 0 are associated with a decreased likelihood to recommend treatment and those greater than 0 with an increased likelihood.
*Normalized coefficient = estimated coefficient/standard error of the estimate.
carried a higher normalized regression coefficient than all other covariates combined. The coefficients of some covariates were significantly related to the treatment decision, though none had a larger impact in the model than did the estimated risk of glaucoma. For example, male sex of the physician and increased patient volume both predicted a lower likelihood to recommend treatment. Furthermore, a self-report of Asian, Black, or ''other'' race and occasional use of a risk calculator were all associated with an increased likelihood to recommend treatment. On the other hand, the relatively low estimate of the variance accounted for by the model (pseudo-R 2 = 0.29) suggested that risk and the other covariates together explain only a modest proportion of the variation in treatment recommendations.
The agreement between the recommendations made with and without a risk estimate was only fair as measured by an average k statistic of 0.37. Had there been no effect of the calculator, this value would have been expected to be higher.
Given that there were changes in recommendations when physicians were provided with a risk estimate, we characterized the nature of those changes. Overall, physicians were slightly more likely to recommend treatment when given the risk calculation than without it (Fig. 3) . Furthermore, the Unsure group underwent the most change with roughly half of the Unsure recommendations changing once physicians were given a risk estimate (Fig. 3) . Most changes in recommendation did so by only 1 level on our 3-step scale. There were few complete reversals induced by knowledge of the risk calculation, with only 4% moving from No to Yes and 6% from Yes to No (Fig. 3) . Plotting the sum of all changes in recommendations (+1 for an increase of 1 level, À 2 for a decrease of 2 levels, etc) for all physicians versus the estimated risk of glaucoma shows that there is a wide range of risk over which recommendations were affected by the calculator (Fig. 4) . When physicians were given the risk estimate, they were less likely to treat cases with lower risk and more likely to treat those with higher risk.
A second approach to describing the effect of the calculator on treatment decisions used the estimated risk at which each physician was equally likely to recommend treatment or no treatment. When not given a risk calculation, the average treatment threshold over all 56 physicians was a 23% chance of conversion to glaucoma over 5 years. With risk calculations, this value decreased significantly to 17% (P<0.001).
Other measures of change in recommendations included the concepts of confidence and inconsistency. The confidence level of physicians (the proportion of recommendations that were not Unsure) increased from 58% without a calculation to 66% with a calculation The relationship between the sum of changes in all physician recommendations and the estimated risk for each pair of case scenarios. We calculated the number of levels by which each physician's recommendation changed for each pair of case scenarios. If the recommendation increased by 1 level when given a risk estimate (eg, Unsure to Yes), a value of +1 was assigned. If a recommendation decreased by 2 levels (eg, Yes to No) a value of À 2 was assigned, and so forth. The sum of these changes over all physicians is plotted versus the risk of glaucoma for each matched pair of cases.
(P = 0.037). The inconsistency measure decreased from 0.04 without the calculator to 0.02 with the calculator (Pr0.001). The smaller inconsistency value indicates that the variability of risk values assigned to each of the 3 categories (Yes, Unsure, No) was reduced when using the calculator.
We determined the potential contribution of individual variables (sex and OHTS risk factors) to the treatment decision with ordinal regression models. The 56 resulting models (1/physician) were evaluated by calculating the proportion of models in which each of the risk factors was significantly related to treatment recommendation. The factors that were most frequently significant were IOP (79% of physician models), CDR (71%), and corneal thickness (70%). Some variables that were significant in the OHTS analysis were included infrequently by physicians, specifically age (16%), PSD (13%), and diabetes (7.1%). Sex is not a risk factor based on the OHTS data, and physicians rarely took it into account (5.3%).
To assess the degree to which clinicians as a group used the OHTS risk factors in treatment recommendations, we combined the responses from all physicians into 2 groups, one without risk estimates and one with the estimates. Ordinal regression was then performed separately on these 2 sets of recommendations. The coefficients from this model were listed in rank order from the most protective against conversion to glaucoma down to the most highly related to conversion. We then compared the rank order of our model coefficients with the estimated coefficients for the OHTS Cox proportional hazard model (Table 4) . When we compared the results of the regression model from the data without a risk calculation to the OHTS coefficients, 2 features showed physicians acting in an opposite direction from the OHTS data. First, physicians were less likely to recommend treatment to older persons, whereas older age is associated with increased risk of glaucoma in the OHTS model. Second, physicians were slightly, but not significantly, influenced toward recommending treatment in diabetics, although diabetes is protective against glaucoma in the OHTS model. For 2 other variables, physicians used different relative weighting in their decision making than might be suggested from the OHTS data. Their recommendations relatively underestimated the contribution of PSD to risk while they overestimated the contribution of IOP.
We compared the physicians' behavior when shown the risk estimate to that without it. When physicians knew the risk value, diabetes was associated with a decreased likelihood to recommend treatment, in contrast to its weight when they were unaware of the risk calculation (Table 4) . A similar reversal occurred with age. When given the risk calculation, physicians were more likely to treat older persons than when they were not aware of the risk calculation. However, even when physicians were aware of the overall risk estimate, the relative ranking of weights for individual risk factors did not exactly match that given by the OHTS results (Table 4) .
CONCLUSIONS
When glaucoma specialists were presented with an OHTS-derived risk estimate along with other relevant patient data, their treatment recommendations were affected in at least 4 ways. First, physicians made a different treatment recommendation in one third of the scenarios when given the risk calculation. Second, the recommendations became less inconsistent and more confident. Third, the average risk threshold for recommending treatment moved closer to values suggested by expert opinion 14 and cost-benefit analysis. 15 Finally, inclusion of a risk calculation produced treatment recommendations that incorporated risk factors in a manner more consistent with the OHTS results.
If one looks only at the distributions of treatment recommendations made with and without a risk estimate, the distribution of Yes, Unsure, and No recommendations were similar. On the other hand, one third of recommendations made in the presence of a risk calculation were different than those made on riskmatched cases without the calculation. To help characterize the changes in recommendations, we first defined the confidence of a physician's recommendations as the proportion of those recommendations that were not Unsure. By this measure, presentation of a risk calculation slightly increased the average confidence of the physicians.
We also measured the changes in recommendations using a term we are calling inconsistency, smaller values of which measure the degree to which cases with similar risk received similar treatment recommendations. The absence of inconsistency is one component of the quality of care. The ability to make repeatable decisions given similar data have been used as a measure of quality in other industries and will likely be more important in medicine as compensation is increasingly linked to ''quality.'' Adding a risk calculation to our case scenarios resulted in inconsistency improving by 50% for the physicians studied. Whether the recommendations are more ''correct'' and lead to better patient outcomes is, of course, another question.
Another measure of physician behavior that changed when they were able to review a risk estimate The coefficients have been recalibrated to match the scale of the hazard ratios from the OHTS. The significance of each parameter in its model is indicated (*P<0.001, wPr0.01).
was their risk threshold for recommending treatment. If one is using the risk of developing glaucoma as the sole determinant of treatment recommendations for ocular hypertensives, then there should be a value of risk above which all patients are recommended treatment and below which they are not. When we used the results from each physician to model their implied risk threshold, we found that the average value was 4.6% per year. This is almost 2.5 times the average risk in the untreated OHTS cohort (1.9%/y). It is also much higher than treatment thresholds suggested by expert opinion (3%/y) 14 or decision analysis (2%/y). 15 When the risk estimate was included, the physicians' average risk threshold decreased to 3.4% per year, still well above the average and suggested values mentioned above. Given these results, it seems glaucoma specialists are tolerant of early glaucoma risk that is above the population average, although knowledge of each patient's estimated risk decreased that tolerance somewhat.
Recommendations made with the risk calculation incorporated the OHTS risk factors more consistently than those made without one. When physicians were not presented with a risk estimate, higher IOP and larger CDR were more predictive of a recommendation to treat than the OHTS results would suggest. The impact of corneal thickness on recommendations was actually similar to that of the OHTS data, despite its recent introduction into glaucoma care.
PSD, in contrast to IOP, CDR, and CCT, was used by few clinicians, despite its importance in predicting development of glaucoma. When presented with risk estimates, however, the clinicians used PSD in a manner more consistent with OHTS. One explanation for the relatively low weight given to PSD is that it was presented out of context. It is likely that clinicians never use this number in isolation but rather view it as one item among many on a typical automated perimetry report.
A diagnosis of diabetes was used by physicians in a manner that seemed opposed to the OHTS data. Without seeing the risk estimate, physicians essentially ignored the protective effect of diabetes found in the OHTS. Some may already be aware that analysis of the combined OHTS and European Glaucoma Prevention Study (EGPS) data found no apparent protective effect of diabetes on conversion to early glaucoma. 3 Because of the conflicting results from the OHTS and EGPS studies, the role of diabetes in ocular hypertension and glaucoma is in flux and physician decision-making reflected this in our study.
Age was the other variable used by physicians in a manner contrary to OHTS risk values. Without the risk calculation, physicians were less likely to recommend treatment as age increased. This illustrates how risk and appropriate practice decisions can differ in a manner that is understandable. The greater chance of conversion to initial glaucoma by those who are older has been seen in every glaucoma study. But, clinicians are aware that a 90-year-old has, actuarially speaking, a relatively small chance of becoming functionally impaired in his/her remaining lifetime. Future risk assessment tools should incorporate the realistic lifespan of the patient.
When given a risk estimate for each patient, the above discrepancies between the relative contributions of risk factors to physician recommendations and the results of the OHTS were reduced. The physicians did not rely exclusively on the risk calculation, however. Their recommendations made with knowledge of each patient's risk still tended to overvalue the role of CDR and IOP. On the other hand, we do not intend to suggest that rigid conformance to the OHTS results is already proven to be a worthwhile goal. Future studies may or may not confirm that the present OHTS-based risk calculators are a useful standard for deciding who should be treated.
In addition to describing the above changes in physician behavior, we also found that recommendations made without knowledge of a risk estimate were related to the risk of developing glaucoma to only a modest degree. Specifically, patient risk of glaucoma coupled with physician characteristics only explained about one fourth of the variability in recommendations. This suggests that there are other, unmeasured factors contributing to current physician decision-making.
This study used simulated patient scenarios and did not require that physicians actually assess the appearance of the optic disc or interpret the full results of a visual field test. Clearly, physicians may behave differently when they view a living patient in the office context. However, our study allowed a rapid and large-scale assessment of physician behavior within these limitations. We hope that future studies will more closely parallel the true officebased decision process, and can include interactive decision-making that takes patient attitudes into account. Variables such as patient age, fear of blindness, dislike of medications, and personal experience with eye disease might affect patient decisions as they do adherence with therapy. 16 The 58 members of the AGS who participated in this study represent about 10% of the approximately 500 names on the AGS mailing list, although it is not clear how many of the addresses belong to active members. Unfortunately, the AGS does not have demographic information for its members so we are unable to determine exactly how similar our group was to the overall AGS membership. On the other hand, we made every effort to ensure a nonbiased sample. We advertised the study to all AGS members, offered monetary compensation to those who participated, and avoided telling them what exactly was being studied in our request to participate. Using zip codes from the participants and from the AGS member list, we determined that there was no geographic bias in recruitment (data not shown). The broad ranges of time in practice, percentage of glaucoma patients, and patient volume, also suggest we captured a diverse group of physicians.
Tools like the glaucoma risk calculator fall into the broad category of clinical decision support. 17 Decision support tools may become increasingly common as electronic medical records make their use more practical.
Given that decision support processes can have a significant impact on clinical practice, physicians should understand the impact such devices have on outcomes and contribute to studies that appropriately evaluate them. [18] [19] [20] [21] [22] Just as most physicians would not adopt a medical or surgical therapy before it has been evaluated, so too should they demand validation of any tool that has the possibility of changing the way they practice.
This study has shown that, at baseline, the risk of glaucoma and physician demographics together only explain one quarter of the variation in specialist treatment recommendations. Furthermore, we showed that a risk calculator can change physician treatment recommendations in a scenario-based setting and that the change may improve the consistency and confidence of clinical decision-making. Finally, the recommendations made in the presence of a risk estimate were more consistent with published results from the OHTS. Although these results suggest that risk calculators might be useful in caring for patients, further research should evaluate the impact of risk calculators in clinical settings and on patient outcomes.
